Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor
Sapporo, Hokkaido
BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor Clinical Trials in Sapporo, Hokkaido
1 recruiting
Sapporo, Hokkaido, Japan
Showing
1–1
of
1
trials
Recruiting
Special Drug Use-results Surveillance of Tafinlar/Mekinist
BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor
Novartis Pharmaceuticals
110 enrolled
68 locations
NCT06262919
Feedback